form of [50:300 mcg/mL at 4 hours after oral ingestion were associated with hepatic damage in 90% of patients; minimal hepatic damage is anticipated if plasma levels at 4 hours are] FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx OTC Availability Rx and/or OTC C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Manufacturer Mallinckrodt Inc. Drug Class Miscellaneous analgesics Related Drugs miscellaneous analgesics acetaminophen , Tylenol , Paracetamol , Mapap , Tylenol Arthritis Pain Pain tramadol , acetaminophen , Tylenol , naproxen , oxycodone , aspirin , ibuprofen , amitriptyline , hydrocodone , clonidine , Norco , More... Fever acetaminophen , Tylenol , naproxen , aspirin , ibuprofen , Aleve , Advil , Ecotrin , Naprosyn , Motrin , Paracetamol , More... Ofirmev Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! really unusual
finally Ofirmev most recent
EmoticonEmoticon